Skip to main content
Caplight Logo









Syndex Bio

Syndex Bio

Private
CambridgeHealthcare & Life Scienceshttps://www.syndex.bio/

Last Round

Seed

Feb 23, 2026

Total Funding Raised

$15.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Syndex Bio is a biotechnology company developing a platform that brings together molecular technologies, instrumentation, and AI to accelerate the understanding, diagnosis, and treatment of disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

mcPCRmethyl-copying PCRDNA methylation analysisliquid biopsyearly cancer detectionepigeneticsmolecular diagnosticsoncology diagnosticsepigenetic biomarkersdiagnostic platformnon-invasive diagnosticsDNA amplificationPCR technologydiagnostic test developmentAI-driven protein engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Syndex Bio Comparables

Compare Syndex Bio with similar companies based on industry and business-model similarity.

Syndex Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epigentek Group Inc.
69%
biomodal
69%
Thermo Fisher Scientific Inc.
65%

Syndex Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 23, 2026

Key People

Founding team and executive leadership

Geoff Smith

CEO and Co-Founder

Founding Team

Jason Betley

Chief Product Officer

Executive Team

Syndex Bio Investors

Notable investors and investment history

Syndex Bio investors
InvestorRounds
ARCH Venture PartnersSeed
+ND CapitalSeed
Meltwind AdvisorySeed
OMX VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 43% MoM, reaching 1.4K.

  • Mar 6, 2026

    Grew 28% QoQ, from 18 to 23 employees.

Syndex Bio Filings

Explore SEC and related filing metadata, where available.

Syndex Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Syndex Bio's valuation, stock price, and market status.

Is Syndex Bio a public or private company?

Syndex Bio is a private company.

What is the current stock price of Syndex Bio?

Syndex Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Syndex Bio worth (valuation)?

Valuation information for Syndex Bio is not publicly available.

Can I buy Syndex Bio stock?

Syndex Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Syndex Bio's last funding round?

Funding round information for Syndex Bio is not publicly available.

Who are the main investors in Syndex Bio?

Investor information for Syndex Bio is not publicly disclosed.

Will Syndex Bio IPO soon?

No public IPO plans have been announced for Syndex Bio.

How can I track Syndex Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Syndex Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range26
Year Founded2022
Last FundingFeb 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?